Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: (sdlittle) From Your Post ... wolf (Reply)
15
Feb 15, 2008 10:33AM
17
Feb 15, 2008 11:26AM

Feb 15, 2008 11:55AM

Feb 15, 2008 11:57AM
1
Feb 15, 2008 12:00PM
4
Feb 15, 2008 01:01PM
1
Feb 15, 2008 02:16PM
4
Feb 15, 2008 02:57PM
18
Feb 15, 2008 03:48PM
1
Feb 15, 2008 04:11PM

I see TPL/Alliacense licensing activity as equivalent to a licensing division within a corporation.  In my company, licensing activities are fluid and visible.  On the other hand, the general direction of corporate strategy is known but the details are not divulged until after the fact.  Milestones in an active successful licensing program are the individual licenses themselves.  Obviously, the frequency of licenses should be much greater than the time it takes to complete milestones at the corporate level.

IMO, TPL/Alliacense is serving its role as licensing division for the company and doing it pretty well.  The verdict is still out on the corporate strategy.  We know the general direction, but the number of milestones we have witnessed is limited.

Based on my philosophy, I think it's unfair to judge PTSC's progress using TPL as the measuring rod.

3
Feb 16, 2008 05:54AM

Feb 17, 2008 02:47AM
Share
New Message
Please login to post a reply